This study investigated the effects of high flow and shear stress on the expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during flow-induced arterial enlargement using a model of arteriovenous fistula (AVF) creation on the carotid artery with the corresponding jugular vein in Japanese white male rabbits. Flow increased 8-fold 7 days after AVF. Endothelial cells (EC) and smooth muscle cells (SMC) proliferated with internal elastic lamina (IEL) degradation in response to high flow and shear stress. Expression of MMP-2 mRNA peaked at 2 days (1700-fold) and maintained high level expression. MMP-9 mRNA gave a 10.8-fold increase within 2 days and decreased later. Their proteins were detected in EC and SMC. Membrane type-1-MMP (MT1-MMP) mRNA increased 121-fold at 3 days and maintained high expression. TGF-␤1 was increased after AVF. Two-peak up-regulation of Egr-1 mRNA was recognized at 1 and 5 days of AVF. These results suggest that high flow and shear stress can mediate EC and SMC to express MMP-2 and MMP-9, which degrade cell basement membranes and IEL to induce arterial enlargement. The disproportional increase in MT1-MMP and TIMP-2 might contribute to MMP-2 activation. Egr-1 and TGF-␤1 might play important roles in this process. © 2002 Elsevier Science (USA) 
INTRODUCTION
Arterial enlargement in response to an increase in blood flow and wall shear stress requires arterial wall structural alteration, which is known as endothelial cell and smooth muscle cell proliferation, extracellular component reorganization, and the gaps of internal elastic lamina, leading to a reduction in wall shear stress to physiological baseline values [1] [2] [3] [4] [5] . Endothelial cells are known to play an essential and important role in this adaptive process [6] . Our previous studies demonstrated that in the model of arteriovenous fistula (AVF) endothelial cell proliferation promoted arterial enlargement, and endothelial cell denudation abolished arterial dilatation [4, 5, 7, 8] . It has been shown that flow-and shear-induced endothelial cell proliferation and migration might contribute to internal elastic lamina gap formation in the rabbit common carotid artery, which might be the first step in flow-induced arterial enlargement [8] .
However, the molecular mechanisms by which endothelial cells induce arterial enlargement in high flow and wall shear stress environment are still not well understood. Interestingly, the evidences of the degradation of the extracellular matrix and the internal elastic lamina gap formation observed in our AVF model [8] suggest a potential role for matrix metalloproteinases (MMPs) in extracellular matrix digestion and reorganization. MMP-2 and MMP-9 are of special interest because they appear to influence further arterial enlargement. Early degradation of endothelial cell and smooth muscle cell basement membranes as well as the internal elastic lamina is known to be a barrier to the proliferation and migration of these cells. This degradation is considered an essential and important first step in flowand shear-induced arterial enlargement. Membrane typeMMPs (MT-MMPs) are activated intracellularly in the secretary pathway by furin-like enzymes. By virtue of its localization and activity, MT1-MMP is endowed with two characteristics important for cell migration: association with the plasma membrane, which focuses matrix digestion close to the cell surface, and the capacity to catalytically activate the precursor of MMP-2, which allows for amplification of the degradative process [9] . The activation of MMPs and their proteolytic potential is tightly controlled by endogenous tissue inhibitors of metalloproteinases (TIMPs) [10] . TIMP-2 forms a 1:1 stoichiometric complex with activated MMP-2, with which they become covalently linked. This complex forms a trimolecular complex on the cell surface with MT1-MMP [11] .
Transforming growth factor beta 1 (TGF-␤1) has been described as a multifunctional regulator; its actions are dependent on species, cell phenotype, growth conditions, and interaction with other growth factors [12, 13] . High flow and elevated wall shear stress have been shown to modulate TGF-␤1 synthesis and activity by arterial endothelial cells [14] . TGF-␤1 usually decreases proteinase activities while it increases proteinase inhibitor synthesis and collagen production, thus favoring fibrogenesis [15, 16] . However, in a few models, TGF-␤1 displays a stimulating effect on MMP-2 or MMP-9 activity [17] [18] [19] . There were few reports which studied the relationship between TGF-␤1 and MMPs in flow-and shear-induced arterial enlargement. Early growth response factor-1 (Egr-1) is an immediateearly response protein induced by a large number of growth factors, cytokines, injurious stimuli [20] , and shear stress [21] , in vitro and in vivo, binding preferentially to GC-rich motifs in DNA. Egr-1 and its role in transcription regulation have potential relevance to the pathogenesis of a variety of vascular diseases. It has been known to be an important activator for multiple endothelial cell gene transcription during vascular remodeling [22] . Recently, Egr-1 increase in endothelial cells upon increased shear stress has been studied in vivo, and MT1-MMP upregulation has been demonstrated to relate to Egr-1 increase [23] .
The purpose of this study is to investigate the time course of early expression of MMPs in response to high flow and wall shear stress. We hope to identify and understand the role and importance of TGF-␤1 and Egr-1 during MMP expression to further our understanding of the molecular pathway of degradation of the extracellular matrix in arterial remodeling in response to high blood flow and shear stress.
MATERIALS AND METHODS

Animal Model
This study was performed on 96 Japanese white male rabbits (weighing 3-4 kg). To induce high flow, AVF was created between the left common carotid artery (CCA) and the left external jugular vein by sterile techniques as described previously [8] . Briefly, animals were anesthetized with inhalation anesthesia; a side-to-side anastomosis was created 5 mm in diameter at a segment 10 mm distal to the thyroid artery branching. Animal care followed the Japanese Community Standard on the care and use of laboratory animals. The animal Research Committee, Akita University School of Medicine, approved the protocols for animal experimentation. Five groups were prepared as AVF 1 day, AVF 2 days, AVF 3 days, AVF 5 days, and AVF 7 days. Nonoperation animals were used as controls.
Blood Flow Measurements and Wall Shear Stress Calculation
Blood flow rate was measured before AVF, after AVF, and before sacrifice with an electromagnetic flow meter (Nihon Kohden Co., Japan) at a standardized location, 10 mm proximal to the thyroid artery branch. After the assumption of laminar flow, wall shear stress (WSS) in dynes per square centimeter was calculated using Poiseuille's formula, WSS ϭ 4BFR/60r 3 , where is the blood viscosity (0.03 poise) [4, 5, 8] , BFR is the blood flow rate (ml/min), and r is the arterial lumen radius (cm).
Animal Sacrifice, Histopathology, and Immunohistochemistry
With sterile technique, animals were anesthetized as described above. After laparotomy, a catheter was introduced into the abdominal aorta at the segment 2 to 3 cm distal to the renal arteries. Animals were then sacrificed by injection of an overdose of pentobarbital solution (100 mg/kg) through the aortic catheter. Five animals in each group were pressure perfusion fixed with 4% paraformaldehyde solution in 0.1 M phosphate buffer (pH 7.4). The left CCAs were processed for histopathological and immunohistochemical analysis. Sections (4 m) were stained with hematoxylin and eosin as well as Elastica Masson's trichrome.
Immunohistochemical analysis of MMP-2, MMP-9, MT1-MMP, TIMP-2, and TGF-␤1 protein locations. Tissue sections were deparaffinized, rehydrated, and incubated with 1% H 2 O 2 in methanol for 30 min. Nonspecific binding was blocked with horse serum (1:200 diluted in PBS) for 20 min at room temperature. After a wash in PBS, the sections were incubated individually with human anti-goat MMP-2, MMP-9, MT1-MMP, TIMP-2, and TGF-␤1 polyclonal antibodies (Santa Cruz Biotechnology, Inc.) at a concentration of 20 g/ml in 1.0% BSA in PBS for 30 min at room temperature in a humid chamber, separately. Sections were then incubated with biotinylated anti-goat antibody (Vector Laboratories, Inc.) for 30 min at room temperature followed by the ABC method (Vector Laboratories, Inc.) according to the manufacturer's protocol. The sections were counterstained with hematoxylin and coverslipped.
Detection of endothelial cell and smooth muscle cell proliferation. Sections (4 m) were prepared as above. After being washed with PBS, the sections were incubated with goat serum (1:200 diluted in PBS) for 20 min. The sections were incubated with mouse anti-Ki-67 monoclonal antibody (1:50 diluted; Becton-Dickinson Immunocytometry Systems, Mountain View, CA) at 20°C for 30 min. After being rinsed in PBS, the sections were incubated with biotinylated anti-mouse IgG antibody for 30 min followed by the ABC method (Vector Laboratories, Inc.) according to the manufacturer's protocol. The sections were counterstained with hematoxylin. All proliferating cells were identified by the presence of brown precipitate over the nuclei. Endothelial cell and smooth muscle cell proliferation rates were expressed as positively stained nuclei per cross section (five sections/animal).
Ultrastructural Analysis
Three animals in each group were pressure perfusion fixed with 3% glutaraldehyde solution in 0.1 M phosphate buffer (pH 7.4) via a catheter for 30 min at 20°C at a pressure of 100 mm Hg. The left CCA was used for transmission electron microscopy (TEM). Specimens were dehydrated through alcohol and embedded in Epon. The sections were stained with lead citrate and uranyl acetate and observed with TEM (LEM2000, Topcon Co., Japan).
En Face Examination of Internal Elastic Lamina
Segments of the left CCA, 4 mm in length, were used for en face examination of internal elastic lamina (IEL) by laser scanning confocal microscopy. They were opened longitudinally and mounted on the glass slide with the lumen side facing up. The segment was covered with a coverslip by glycerol/PBS for observation under a laser scanning confocal microscope with stimulation of a HeNe laser (488 nm). The structure of IEL was visible owing to the autofluorescent property of elastin, which emits green fluorescence under laser stimulation.
Substrate Gel Zymography
Frozen carotid arterial samples (n ϭ 3) were pulverized under liquid nitrogen and extracted in ice-cold 50 mM Tris-HCl buffer, pH 7.5, containing 10 mM CaCl 2 , 2.0 M guanidine hydrochloride, and 2.5% Triton X-100. Samples were dialyzed with dialysis buffer, pH 7.5, containing 50 mM Tris-HCl and 2.5% Triton X-100. Samples were normalized to total protein content. For detection of MMP-2 and MMP-9, equal amounts of tissue extract protein (20 g), assayed by using the BCA protein assay (Bio-Rad), were loaded on each lane and run in parallel in 10% SDS-PAGE gels containing 1% gelatin. Gels were washed with Triton X-100 (2.5%) to remove SDS and then incubated overnight (37°C) in developing buffer (50 mM Tris base and 10 mM CaCl 2 ). Zones of lysis were visualized after the gels were stained with 0.5% Coomassie blue R-250. Densitometric analysis of lytic bands for MMP-2 and MMP-9 was performed by public domain software NIH Image version 1.61.
Quantitation of mRNA for MMP-2, MMP-9, MT1-MMP, TIMP-2, TGF-␤1, and Egr-1
Total RNA extraction and cDNA synthesis. Left CCA (n ϭ 5 in each group) (80 -100 mg) was homogenized in TRIzol reagent (Gibco BRL), and total RNA was extracted according to the manufacturer's protocol. Contaminated DNA was removed by treatment with 5 units of DNase I (Invitrogen) at 37°C for 45 min followed by inactivation at 65°C for 10 min. A total of 1 g of RNA was reverse transcribed with Superscript II reverse transcriptase (Invitrogen).
Primers. Rabbit MMP-2, MMP-9, MT1-MMP, TIMP-2, TGF-␤1, and Egr-1 primers were designed from the rabbit cDNA of MMP-2 (AJ250102, forward primer 5Ј-cagtttccttggcaggcta-3Ј and reverse primer 5Ј-gaccaccttctcgatttcca-3Ј), MMP-9 (L36050, forward primer 5Ј-ccatgccaggagtacctgtt-3Ј and reverse primer 5Ј-ctcgaaggtctggaatttgc-3Ј), MT1-MMP (U73940, forward primer 5Ј-cagctttatgggagccagtc-3Ј and reverse primer 5Ј-tgttcctcaccctccagaac-3Ј), TIMP-2 (AF069713, forward primer 5Ј-cgagaaggaggtggactctg-3Ј and reverse primer 5Ј-gccttccctgcaatgagata-3Ј), TGF-␤1 (AF000133, forward primer 5Ј-cggcagctgtacattgactt-3Ј and reverse primer 5Ј-agcgcacgatcatgttggac-3Ј), and Egr-1 (AJ291320, Egr-1 forward primer 5Ј-gacagcagccccatctactc-3Ј and reverse primer 5Ј-ctgctgcggaaacaggtagt-3Ј). These primers had previously been tested in rabbits to enable us to amplify specific PCR products. Housekeeping gene ␤-actin primers were also designed from the rabbit cDNA of ␤-actin (AF309819, forward primer 5Ј-ggacctgaccgactacctca-3Ј and reverse primer 5Ј-ggcagctcgtagctcttctc-3Ј) and tested in rabbits to get specific PCR product.
Standard curve. The PCR products amplified by the primers mentioned above were purified and quantified. A total of 1 ng of each PCR product was generated by serial dilution. Real time PCR was performed following the protocol below. PCR products from each primer pair were analyzed and standard curves were created.
Real time PCR.
Real time PCR was performed using the GeneAmp 7700 Sequence Detection system (Applied Biosystems) according to the manufacturer's instructions. Reactions were performed in a 20-l volume with 0.8 M primers and 1.0 g cDNA and SYBR Green PCR Master mix (Applied Biosystems). A typical protocol included a 2-min 50°C for optimal AmpErase UNG enzyme activity step and a 10-min 95°C for activation AmpliTag Gold DNA polymerase step, followed by 40 cycles with a 95°C denaturation for 15 s and 1-min annealing and extension at different annealing temperatures. To confirm amplification specificity, the PCR products from each primer pair were subjected to a standard curve analysis and normalized by calculating the ratio against ␤-actin expression.
Statistical Analysis
All data were expressed as means Ϯ SD. ANOVA and Bonferroni protected least significant difference tests were used for statistical analysis of the means. Differences were considered significant at P Ͻ 0.05.
RESULTS
Hemodynamic Parameters
Mean baseline blood flow in the left CCA (20.1 Ϯ 1.3 ml/min) was similar before AVF creation in all groups. It increased 3-fold immediately after AVF creation and progressively increased as the AVF opened, becoming 7.1-fold (P Ͻ 0.001) after 7 days of AVF (Table I) , which coincided well with our previous data [8] .
Changes in lumen radius showed enlargement of the artery 3 days after AVF creation; 7 days later it was significantly enlarged compared to controls (1.34 Ϯ 0.02 mm vs 1.09 Ϯ 0.07 mm, P Ͻ 0.001).
WSS in the left CCA significantly increased 1 day after AVF creation. It peaked at 3 days of AVF and decreased 5 days later as the arteries enlarged (Table I) .
Histopathological Analysis
Endothelial cells staining positive for Ki-67 appeared 1 day after AVF and peaked at 3 days (Fig. 1 , Table II ). The Note. ECPR, proliferation rate of endothelial cell (positive EC nuclei/section); sub-IELPR, proliferation rate of smooth muscle cells located in subinternal elastic lamina (positive SMC nuclei/section); DMPR, proliferation rate of smooth muscle cells located in deep media (positive SMC nuclei/section).
* P Ͻ 0.0001 compared to controls and AVF1d. † P Ͻ 0.0001 compared to AVF2d. ‡ P Ͻ 0.0001 compared to AFV3d. ¶ P Ͻ 0.0001 compared to AVF5d. Note. BFR, blood flow rate (ml/min); WSS, wall shear stress (dynes/cm 2 ); LR, lumen radius (mm). * P Ͻ 0.0001 compared to controls. † P Ͻ 0.0001 compared to AVF1d and AVF2d. ‡ P Ͻ 0.0001 compared to AVF3d. ¶ P Ͻ 0.0001 compared to AVF5d.
IEL became thin and nibbled focally 2 days after AVF creation. Many small broken foci of IEL appeared at day 3 (Fig. 1C) . IEL broke into pieces significantly 5 days and more severely 7 days after AVF (Fig. 1D) . Ki-67-positive endothelial cells were mainly located in the IEL rupture area (Fig. 1H ) at 7 days of AVF. Several Ki-67-positive smooth muscle cells appeared 2 days after AVF and increased in time course (Table II) . Almost half of them were located in the subinternal elastic lamina zone (sub-IEL, 1-2 layers of the smooth muscle cells beneath IEL) (Figs. 1G and 1H) , and others were in the deep media zone (all other layers of the medial smooth muscle cells). Several smooth muscle cells beneath IEL changed their circular orientation to a longitudinal orientation parallel to the flow direction 7 days after AVF (Fig. 1D) . TEM examination revealed the endothelial cell basement membrane to be disconnected 2 days after AVF with the IEL nibbled (Fig. 2B) . Smooth muscle cells beneath the endothelium changed their orientation; their surrounding elastic fibers fragmented 7 days after AVF (Fig. 2C) . (original magnification, ϫ1000) . Immunohistochemical staining of Ki-67: Detection in endothelial cells occurred 1 day after AVF (E, arrowhead), became significant 2 days after AVF (F), and peaked at 3 days (G). Detection in smooth muscle cells was at 3 days after AVF (G, asterisk). The positively stained endothelial cell and smooth muscle cell nuclei were mainly in the IEL rupture area 7 days after AVF (H) (original magnification, ϫ1000). IEL, internal elastic lamina.
En Face Examination of Internal Elastic Lamina
In carotid artery with normal flow, regular and small fenestrae were found in the IEL, showing orientation par-
FIG. 3.
En face observation of IEL with a laser scanning confocal microscope. The images were obtained with the laser beam focused on the IEL level. The IEL appeared green due to its autofluorescence. The flow direction was from left to right. Compared to control artery (A), 1 day after AVF, IEL fenestrae were slightly enlarged and regularly orientated following the flow direction (B). The fenestrae were enlarged significantly and disintegrated partially 2 days after AVF (C). Fenestrae lost their flow direction orientation. IEL became thin and fenestrae were enlarged and disintegrated diffusely 3 days after AVF (D). Five days after AVF, the IEL ruptured partially, forming big holes (arrow) (E). Many small and large pieces (arrow) of ruptured IEL were observed 7 days after AVF (F). Bar ϭ 50 m. allel to flow direction. These fenestrae became enlarged and irregular 2 days after AVF (Fig. 3B ), but they still kept their orientation. IEL thinned 3 days after AVF, and fenestrae were enlarged and disintegrated and failed to follow the flow direction (Figs. 3C and 3D) , which was just at the time of endothelial cell and smooth muscle cell proliferation and function. The IEL broke 5 days after AVF (Figs. 3E  and 3F ).
Expression of MMP-2 and MMP-9
MMP-2 and MMP-9 mRNA was detected in all groups. The MMP-2 mRNA level was up-regulated significantly 1 day after AVF, peaked at 2 days (more than 1700-fold increase), and kept a high expression compared to controls at all time points examined (Fig. 4) . The MMP-9 mRNA level was increased 10.8-fold 2 days after AVF and reduced 3 days after AVF (Fig. 4) . Immunohistochemical staining of MMP-2 and MMP-9 proteins was detected in endothelial cells with heavy staining at 1-3 days of AVF for MMP-2 (Figs. 5A-5C) and 1-2 days of AVF for MMP-9 (Figs. 5E and 5F). They were also detected in the smooth muscle cells located in the sub-IEL zone at 7 days of AVF creation (Figs. 5D and 5H).
Activity of MMP-2 and MMP-9
MMP gelatinolytic activity in the common carotid arteries was increased after AVF creation (Fig. 6) . At 1 day, MMP-2 activity increased 10-fold and continued to increase 40-fold at 7 days of AVF creation. Pro-MMP-2 activation was detectable 1 day after AVF and peaked at 7 days (4-fold increase compared to controls). Pro-MMP-9 activation was detectable after AVF creation and peaked at 7 days (10-fold compared to controls). In contrast, MMP-9 activity was detectable from 1 to 3 days of AVF creation.
Expression of MT1-MMP and TIMP-2
MT1-MMP mRNA was significantly upregulated at 1 day of AVF (51.2-fold compared to controls), peaked at 3 days of AVF (121-fold), and remained at a high level of expression (Fig. 4) . MT1-MMP protein was detected both in endothelial cells and in smooth muscle cells 1 day after AVF, strongly in endothelial cells. The heavy staining was seen at 3 days of AVF. The smooth muscle cells detected with MT1-MMP were mainly located in the inner zone of the media, especially beneath the internal elastic lamina (Figs. 5I-5L ). TIMP-2 mRNA was upregulated at 1 day of AVF creation (7.3-fold) and remained at a relatively high   FIG. 4 . Expression of MMP-2, MMP-9, MT1-MMP, and TIMP-2 mRNA in the left common carotid artery after AVF creation. MMP-2 was up-regulated 1 day after AVF and peaked at 2 days. It kept a long-term high expression in all time points examined compared to control. MMP-9 was up-regulated 1 day after AVF and peaked at 2 days. It decreased to control levels 5 days later. MT1-MMP was up-regulated significantly 1 day after AVF. Long-term high expression was observed. TIMP-2 was up-regulated parallel to MMP-2, with a significant increase 3 days after AVF creation. *P Ͻ 0.0001 compared to controls; †P Ͻ 0.0001 compared to AVF1d; ‡P Ͻ 0.0001 compared to AVF2d; ¶ P Ͻ 0.0001 compared to AVF3d; §P Ͻ 0.0001 compared to AVF5d. Specific PCR product bands (199 bp for MMP-2, 204 bp for MMP-9, 199 bp for MT1-MMP, and 195 bp for TIMP-2) were detected in 2% agarose gel after 40 cycles of real time PCR.
expression at all examined time points, taking unequal rank with MT1-MMP (Fig. 4) . TIMP-2 protein was detected in endothelial cells and smooth muscle cells, weakly in control arteries. The heavy staining of TIMP-2 protein was seen 3 days after AVF. The staining is stronger in smooth muscle cells than in endothelial cells, which were diffuse in all smooth muscle cells in the media (not shown).
Expression of TGF-␤1
Appropriate-size TGF-␤1 mRNA was detected in all groups (Fig. 7) , suggesting a constitutive expression of TGF-␤1. There was a 3-fold increase in TGF-␤1 mRNA levels 1 day after AVF creation. It peaked at 5 days of AVF creation, increasing 4.5-fold. TGF-␤1 mRNA levels were slightly reduced 7 days after AVF. Immunohistochemical staining of TGF-␤1 protein was localized in the endothelial cells (Figs. 8A-8D) 1 day after AVF, and heavy staining was present 3 days after AVF. It was also detected in the smooth muscle cells located in the media.
Expression of Egr-1 mRNA
Egr-1 mRNA level was up-regulated significantly and shortly 1 day after AVF creation (2.1-fold) and decreased to control levels at 2 days of AVF. Five days later it was up-regulated significantly again till 7 days of AVF creation (2.7-fold at 5 days and 3.5-fold at 7 days) (Fig. 7) . The first peak expression of Egr-1 mRNA was just the beginning period of arterial diffuse activation under high flow and shear stress conditions. The second peak expression of Egr-1 mRNA was in the period of arterial enlargement due to high flow and shear stress.
DISCUSSION
Arterial enlargement in response to high flow and wall shear stress is endothelial cell dependent [4 -8] . However, the endothelial mechanisms responsible for artery adaptation to chronically altered flow are not fully elucidated. In cases of chronically enhanced blood flow, the resulting arterial enlargement is far beyond the capability of distension owing to vasoactive dilatation, which involves structural remodeling [8, 24] . An increase in expression of MMP-2 and MMP-9 was associated with a sudden increase in blood flow and wall shear stress. This finding does not exclude the possibility that other MMPs were induced and activated by the increase in blood flow and wall shear stress and may have contributed to matrix degradation. In recent reports, the role of MMP-2 and MMP-9 in chronic flowinduced arterial enlargement was overlooked [25] . In comparing the expression and activity of MMP-2 and MMP-9 in response to high flow and wall shear stress, it was recognized that the high expression and activity of MMP-2 were significant and long term. On the contrary, MMP-9 expression and activity were relatively low and instantaneous. This short-term expression of MMP-9 confirmed the findings by others that endothelial cells [26] and smooth muscle cells [27] do not continuously secrete this enzyme. This might demonstrate that MMP-2 plays a much longer and more important role in the degradation and fragmentation of IEL compared to MMP-9, even though both MMP-2 and MMP-9 had contributed to the degradation of the cell basement membrane, allowing cells to proliferate, migrate, and reorientate through the extracellular matrix.
The techniques emphasized in this study permitted the identification of cells that elaborate MMP-2 and MMP-9. Endothelial cells were clearly identified to elaborate MMP-2 and MMP-9 under high flow and wall shear stress, and smooth muscle cells were also identified to elaborate them later. Endothelial cells, which are the sensors of increased flow and wall shear stress, can release MMPs [28, 29] . Also, endothelial cells exposed to elevated wall shear stress might secrete factors that trigger MMP production by themselves and/or smooth muscle cells. This study showed that MMP-2 and MMP-9 were expressed mainly in endothelial cells and later in smooth muscle cells, which demonstrated that both cells might contribute to flow-induced arterial enlargement.
Many studies showed that the activation of pro-MMP-2 is well correlated with the expression of MT1-MMP [30 -32] . MT1-MMP is capable of binding and activating pro-MMP-2. The process by which activation occurs is complex and is thought to involve interactions among MT1-MMP, pro-MMP-2, and TIMP-2 [33] . Usually they form a trimolecular complex on the cell surface as 1:1:1. The concentrations of each component as well as the spatial relationships of these protein complexes are critical in determining the net level of MMP-2 activation which occurs: if TIMP-2 is present in greater concentration than MT1-MMP, a significant fraction of the MT1-MMP will be bound and inhibited by TIMP-2, leaving few free to bind and activate MMP-2. Data shown in this study demonstrated that high flow and shear stress induced both MT1-MMP and TIMP-2 mRNA expression, but were not equal. The disproportional increase in MT1-MMP and TIMP-2 left a lot of free MT1-MMP to bind and activate MMP-2. Morphological findings in this model proved the correctness of these molecular results. MT1-MMP mRNA continually up-regulated during AVF, and protein detection at a later time revealed MT1-MMP located both in endothelial cells and in smooth muscle cells, which might maintain MMP-2 activation in the long term, contributing to further smooth muscle cell proliferation and arterial enlargement.
Egr-1 is known to be an important activator for multiple endothelial cell genes transcribed during vascular remodeling [34] , with increasing levels in endothelial cells upon mechanical stress or increased shear stress. Hass et al. [35] demonstrated in vitro that increased binding of Egr-1 to the MT-MMP promoter correlates with enhanced transcriptional activity, whereas mutations in the Egr-1 binding site abrogate the increased transcription of MT1-MMP in the stimulated cells. They identify Egr-1-mediated transcription of MT1-MMP as a mechanism by which endothelial cells can initiate an invasive phenotype in response to an alteration in extracellular matrix environment. Consistent with a flow and shear stress induction of Egr-1 and subsequent transcription of MT1-MMP, the time course of increase in Egr-1 and MT1-MMP mRNA correlated closely with the processes of endothelial cell and smooth muscle cell proliferation and migration, matrix contraction, and further arterial enlargement in this model. Two-peak up-regulation of Egr-1 in this model might be very important for maintaining the MT1-MMP long-term increase during the high flow and shear stress conditions to induce arterial enlargement, even though there is no further evidence as yet to confirm this. The demonstration of MT1-MMP transcriptional regulation via Egr-1 might support this evidence that Egr-1 is a key transcription factor involved in the initiation of a migratory 
FIG. 6.
Gelatinolytic activity in the left common carotid artery after high flow. MMP-2 activity was induced as early as 1 day after AVF and increased significantly at all time points investigated. Activated-MMP-2 increased significantly and peaked at 7 days of AVF. Gelatinolytic activity associated with MMP-9 was induced 1 day after AVF, and the activated-MMP-9 peaked around 1-3 days of AVF even through pro-MMP-9 continued to increase. MW indicates molecular weights. Lytic bands corresponding to apparent MW of MMP-2 and MMP-9 were quantified by densitometry (bottom). *P Ͻ 0.0001 compared to controls; †P Ͻ 0.0001 compared to AVF1d. and invasive phenotype in endothelial cells as well as smooth muscle cells in flow-and shear-stress-induced arterial enlargement.
TGF-␤1 is a multifunctional cytokine that has both positive and negative effects on endothelial cell functions [36, 37] . Shear stress controls the expression of a number of genes involved in endothelial cell functions, including TGF-␤1 in vitro and in vivo [38, 39] . This study demonstrated TGF-␤1 up-regulation after high flow and shear stress in endothelial cells and medial smooth muscle cells. TGF-␤1 was considered an important modulator of MMPs and thus played a key role in matrix degradation [40] . It is known to regulate extracellular matrix by stimulating the synthesis of its components or by inhibiting matrix degradation through down-regulation of some proteinases or up-regulation of some proteinase inhibitors [41] [42] [43] . However, TGF-␤1 has been shown to up-regulate both MMP-2 and MMP-9 in cultured fibroblasts [44] and endothelial cells [45] . Our data showed MMP-2 and MMP-9 up-regulation keeping abreast of TGF-␤1 up-regulation. Even though there is not enough direct evidence to demonstrate that TGF-␤1 up-regulates MMP-2 and MMP-9 expression in this model, we could deduce that TGF-␤1 should either up-regulate the expression of MMP-2 and MMP-9 or help to activate their activity so as to induce arterial enlargement.
In summary, in this experimental model our study showed that high flow and wall shear stress induced significant endothelial cell and smooth muscle cell proliferation, accompanied by significant increases in MMP-2 and MMP-9, which were expressed by either endothelial cells or smooth muscle cells. MMP-2 and MMP-9 possibly degraded cell basement membranes and IEL, allowing proliferating endothelial cells to migrate and realign into new enlarged areas and allowing proliferating smooth muscle cells to reorientate in the media and adapt to arterial enlargement. MT1-MMP upregulation might be able to activate pro-MMP-2. Egr-1 and TGF-␤1 expression might play a very important role in this process, such as up-regulating the expression of MMP-2, MMP-9, and MT1-MMP or activating their enzyme activity. To confirm these roles, additional experiments are still necessary. Potential mechanisms for flowand shear-induced arterial enlargement might be similar to the process of angiogenesis. Further, this model may indicate a new pathway for understanding the mechanisms of arterial enlargement.
FIG. 7.
Expression of TGF-␤1 and Egr-1 mRNA in the left common carotid artery after AVF creation. TGF-␤1 was up-regulated 1 day after AVF and kept a long-term high expression. The first peak expression of Egr-1 was at 1 day of AVF, and the second peak expression of Egr-1 was at 5 and 7 days of AVF. *P Ͻ 0.0001 compared to controls; †P Ͻ 0.0001 compared to AVF1d; ‡P Ͻ 0.0001 compared to AVF2d and AVF3d;
¶ P Ͻ 0.0001 compared to AVF5d. Specific PCR product bands (271 bp for TGF-␤1 and 189 bp for Egr-1) were detected in 2% agarose gel after 40 cycles of real time PCR. 
